comparemela.com
Home
Live Updates
Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia : comparemela.com
Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia
/PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases,...
Related Keywords
Australia ,
China ,
Cambridge ,
Cambridgeshire ,
United Kingdom ,
Chinese ,
Australian ,
Frederick Beddingfield ,
Inds Kira ,
Australian Therapeutic Goods Administration ,
Prnewswire Kira Pharmaceuticals ,
Chinese National Medical Products Administration ,
Drug Administration ,
Orphan Drug Designation ,
Kira Pharmaceuticals ,
comparemela.com © 2020. All Rights Reserved.